Program

Click here to download the MSWord version of the full program.
Click here to download the Preliminary Program for Discovery to Development Symposium III (july 12, 2012)

MONDAY, July 2nd

08:30 – 09:00

Registration

 

09:00 – 09:15

OFFICIAL OPENING – 4th Summer School on Medicines (SSM4)

 

Denis deBlois, Chairman, SSM4 Scientific Committee
Pierre Moreau, Dean, Faculty of Pharmacy Université de Montréal
Michelle Savoie, Director, Montréal InVivo
Pierre Cordelier, Université Paul-Sabatier/ Oncopole, Toulouse

SESSION 1 : NEW MEDICINES: AN OVERVIEW FROM IDEA TO MARKET

Chairperson: Denis deBlois, Université de Montreal

09:15 – 10:15

Drug discovery

Denis de Blois, Université de Montréal, Québec

10:15 – 10:45

Health Break

10:45 – 11:45

Translational medicine

Denis de Blois, Université de Montréal, Québec
Brian White-Guay, Université de Montreal, Québec

11:45 – 13:15

Lunch

13:15 – 14:30

Clinical development

Brian White-Guay, Université de Montreal, Québec

14:30 – 15:30

Molecules and Money

Jeffery Elliott, Sectoral Asset Management, Montreal

15:30 – 16:00

Health Break

16:00 – 17:00

Evolving models of pharma R&D: Introductory remarks & panel

Philippe Walker, V-P Astra Zeneca R&D

17:00 – 19:00

Welcome Reception in Montreal

TUESDAY, July 3rd

SESSION 2 : DRUG DISCOVERY

Chairperson: Denis de Blois, Université de Montreal

08:30 – 9:15

Target identification and validation

Marc Servant, Université de Montreal

9:15 – 10:00

Assessing target function

Michael A Adams, Queen's University, Kingston, ON

10:00 – 10:30

Health break

10:30 – 11:15

The medicinal chemistry of small molecules

Eric Marsault, Université de Sherbrooke

11:15 – 12:00

Case example: Preclinical development of a molecule with an original mechanism of action against leukemia

Christian Recher, Toulouse

12:00 – 13:30

Lunch

13:30 – 14:15

Biologicals: discovery and development

Jean-François Gauchat, Université de Montréal

14:15 – 15:00

Targeting shifting targets: constraints in the area of antibacterials

Karine Auclair, McGill University

15:00 – 15:30

Health break

15:30 – 16:15

Gene therapy: from preclinical to phase I clinical trials

Pierre Cordelier, Toulouse

16:15 – 17:00

Panel Discussion

WEDNESDAY, July 4th

SESSION 3: NONCLINICAL DEVELOPMENT

Session Chairperson: Brian White-Guay, Université de Montreal

8:30 – 9:15

The absorption, distribution, metabolism and excretion of drugs

Véronique Michaud, Université de Montréal

9:15 – 10:00

Current Trends in Non-Clinical Safety Testing

Simon Authier, CiToxLAB

10:00 – 10:30

Health break

10.30 – 11:15

Unexpected & Unusual Adventures in Chemistry, Manufacturing & Controls

Patrick Colin, Chief Development Officer, GiCare Pharma

11:15 – 12:00

Panel Discussion

12:00 – 13:30

Lunch

SESSION 4: CASE STUDY IN DRUG DISCOVERY AND DEVELOPMENT (I)

Development of GIC-1101: A novel analgesic with dual mechanisms of action
Case Study presented by: Patrick Colin, Chief Development Officer, GiCare Pharma

13:30 – 14:00

Case presentation and outline of challenges

14:00 – 15:00

Group session: Students work in small teams to tackle the challenges

15:00 – 15:30

Health break

15:30 – 17:00

Each team reports / General discussion

THURSDAY, July 5th

SESSION 5 : CLINICAL DEVELOPMENT

Chairperson: Brian White-Guay, Université de Montreal

08:30 – 9:15

ADME in humans : Issues and challenges

Jacques Turgeon, Université de Montreal

9:15 – 10:00

Learning trials : exposure – response and dose selection

Richard Lalonde, Pfizer, USA

10:00 – 10:30

Health break

10:30 – 11:15

Biomarkers in drug development

Patrice Hugo, Senior Global Director, LabCorp Clinical Trials

11:15 – 12:00

Panel Discussion

12:00 – 13:30

Lunch

13:30 – 14:15

Regulatory strategy and interactions: early development

Patrick Colin, GiCare Pharma, Canada

14:15 – 15:00

Regulatory strategy and interactions : late development

Brian White-Guay, Université de Montréal

15:00 – 15:30

Health break

15:30 – 16:15

From discovery to life cycle management: an integrated view of drug development

Robin Goldstein, consultant, Boston

16:15 – 17:00

Panel Discussion

FRIDAY, July6th

SESSION 6: CLINICAL TRIALS

Session Chairperson: Denis Querleu, Université Paul-Sabatier, McGill University

8:30 – 9:15

Late development design, analysis & interpretation of clinical trials

Raymond Bain, Merck USA

9:15 – 10:00

Late clinical development issues and challenges

Ted Reiss, Vanderbilt University, Nashville, USA

10:00 – 10:30

Health break

10.30 – 11:15

Value vigilance: What should we be looking for ?

Pierre Anhoury, Accenture, Toulouse

11:15 – 12:00

Panel Discussion

12:00 – 13:30

Lunch

SESSION 7: CASE STUDY IN DRUG DISCOVERY AND DEVELOPMENT (II)

Discovery of Montelukast: Endpoint / comparator selection; target product profile
Case Study presented by: Ted Reiss, Vanderbilt University, Nashville, USA

13:30 – 14:00

Case presentation and outline of challenges

14:00 – 15:00

Group session: Students work in small teams to tackle the challenges

15:00 – 15:30

Health break

15:30 – 16:15

Each team reports

16:15 – 17:00

How it really happened

SUNDAY, July 8th

9:00

Bus departure for Quebec City

12:00

Free Visit (PM)

19:00

Dinner in Old Quebec

MONDAY, July 9th

SESSION 8: MOLECULAR BIOMARKERS AND DEVELOPMENT OF POINT OF CARE DIAGNOSTICS FOR INFECTIOUS DISEASES

Session Chairperson: Michel G Bergeron, Université Laval

9:00 – 12:00

A medical practice revolution : molecular diagnosis of infectious diseases

Michel G Bergeron, Director and Founder, Centre de Recherche en Infectiologie

12:00 – 13:30

Lunch

SESSION 9: INNOVATIVE VACCINE DEVELOPMENT PLATFORM

Session Chairperson: TBA

13:30 – 17:00

Medicago Research Center

Louis-Philippe Vézina, Medicago Inc.

17:00

Departure for Montreal (bus)

TUESDAY, July 10th

SESSION 10 : PHARMACOGIVILANCE AND RISK MANAGEMENT

Chairperson: Sylvie Perrault, Université de Montréal

08:30 – 9:15

Benefit-risk assessment in clinical decision making

James Brophy, McGill University

9:15 – 10:00

Pharmacovigilance and risk management considerations in Canada

Ariel E. Arias, Ctr for Blood and Tissues Evaluation, Health Canada

10:00 – 10:30

Health break

10:30 – 11:15

Global implementation of pharmacovigilance plans

Gervais Tougas, Novartis , Bâle

11:15 – 12:00

Panel Discussion

12:00 – 13:30

Lunch

SESSION 11 : MARKET ACCESS AND HEALTH TECHNOLOGY ASSESSMENT (HTA)

Chairperson: Jean Lachaine, Université de Montreal

13:30 – 14:15

The path towards reimbursement of pharmaceutical innovations in Canada

Frédéric Lavoie, Pfizer

14:15 – 15:00

Market Access – Third Payer Perspective

Reiner Banken, INESS

15:00 – 15:30

Health break

15:30 – 16:15

HTA methodologies

Jean-Eric Tarride, McMaster University

16:15 – 17:00

Panel Discussion

WEDNESDAY, July 11th

SESSION 12: FINANCING THE VALUE CHAIN

Chairperson: (TBA)

08:30 – 9:15

From innovation to value

Anne-Marie Larose, Hema-Quebec

9:15 – 10:00

New trends in financing opportunities, models for start-ups

Elizabeth Douville, Amorchem

10:00 – 10:30

Health break

10:30 – 11:15

Global financing and partnerships

Elizabeth Stoner, MPM Capital, New-York

11:15 – 12:00

Panel Discussion

12:00 – 13:30

Lunch

SESSION 13: BUSINESS DEVELOPMENT

Chairperson: (TBA)

13:30 – 14:15

Biopharmaceutical Stakeholders: understanding the life science ecosystem

Michelle Savoie, Université de Montréal,

14:15 – 15:00

Pharma vs. Biotech

Luc Vachon

15:30 – 16:15

Panel Discussion

16:15 – 17:00

Poster session

THURSDAY, July 12th

SYMPOSIUM : Facing the current innovation challenges in drug discovery and development

Click here to download the program.

 

FRIDAY, July 13th

SESSION 14: NEW STRATEGIES

Session Chairperson: Jordi Quintana, Parc Científic de Barcelona

8:30 – 9:15

Genomics: present and future impact

Ivo Gut, Director, Natl Ctr for Genomic Analysis, Barcelona

9:15 – 10:00

Public –Private partnerships (PCB-Chembiobank)

Jordi Quintana, Parc Científic de Barcelona

10:00 – 10:30

Health break

10.30 – 11:15

Pre-competitive research / Open Innovation

Max Fehlmann, CQDM

11:15 – 12:00

Panel Discussion

12:00 – 13:30

Lunch

SESSION 15: CAREER PLANNING

Chairperson: Michelle Savoie, Université de Montréal et Montréal InVivo

13:30 – 14:15

Career profiles in life sciences. What are the opportunities?

Patrick Colin, Chief Development Officer, GiCare Pharma

14:15 – 15:00

Career development: what does it take?

Luc Vachon

15:00 – 16:00

Panel Discussion

16:00 – 16:15

SSM4 Closing comments and overture towards SSM5

Denis deBlois